Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AbbVie Inc. Director's Dealing 2013

Dec 20, 2013

29755_dirs_2013-12-20_3ffdab10-3d4f-48d3-820a-ff6cfc5a6313.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2013-12-19

Reporting Person: SALEKI-GERHARDT AZITA (SVP, Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-12-19 Common stock, $0.01 par value M 304 $28.3745 Acquired 414 Indirect
2013-12-19 Common stock, $0.01 par value M 2186 $28.4057 Acquired 2600 Indirect
2013-12-19 Common stock, $0.01 par value F 1682 $54.32 Disposed 918 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-12-19 Option (right to buy) $28.3745 M 304 Disposed 2014-02-19 Common stock (304) Indirect
2013-12-19 Option (right to buy) $28.4057 M 2186 Disposed 2014-02-19 Common stock (2186) Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common stock, $0.01 par value 66703 Direct
Common stock, $0.01 par value 1687 Indirect

Footnotes

F1: Balance in the AbbVie Savings Program as of December 19, 2013.

F2: The reporting person disclaims beneficial ownership of all securities held by her spouse.